Biolife Solutions (BLFS) Accounts Payables (2010 - 2026)

Biolife Solutions (BLFS) has 17 years of Accounts Payables data on file, last reported at $3.8 million in Q1 2026.

• On a quarterly basis, Accounts Payables rose 13.74% year-over-year to $3.8 million in Q1 2026; TTM through Mar 2026 was $3.8 million, a 13.74% increase from a year earlier, with the FY2025 full-year figure at $1.5 million, down 55.77% from the prior year.
• Accounts Payables for Q1 2026 stood at $3.8 million, up from $1.5 million in the prior quarter.
• Over the last five years, Accounts Payables for BLFS reached as high as $15.5 million in Q1 2023 and fell as low as $1.5 million in Q4 2025.
• Historically, Accounts Payables has averaged $7.2 million across 5 years, with a median of $4.2 million in 2024.
• Across the five-year window, Accounts Payables jumped 173.88% in 2022 and slumped 85.23% in 2023, its largest moves.
• Year by year, Accounts Payables stood at $15.4 million in 2022, then tumbled by 85.23% to $2.3 million in 2023, then jumped by 48.02% to $3.4 million in 2024, then plunged by 55.77% to $1.5 million in 2025, then surged by 152.36% to $3.8 million in 2026.
• Per Business Quant data, the three most recent Accounts Payables figures were $3.8 million in Q1 2026, $1.5 million in Q4 2025, and $2.9 million in Q3 2025.